痴呆症对话:为医学学生举办教育研讨会
Kayla S Murphy1, Grant Flindt2, Michelle Nguyen2
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Journal of the American Geriatrics Society
|September 11, 2025
概括
为医学学生举办的痴呆症护理研讨会,提高了他们对痴呆症和痴呆症的信心和知识. 这次年度研讨会将继续根据学生的意见进行改进,以改善移情性痴呆症护理教育.
科学领域:
- 医学教育 医学教育
- 老年病的医生 老年病的医生
- 神经学 神经学
背景情况:
- 医学学生需要在痴呆症护理方面接受专业培训.
- 对患有痴呆症和妄想症的患者来说,同情的护理至关重要.
- 早期接触痴呆症护理可以培养医生的兴趣.
研究的目的:
- 评估痴呆症研讨会对医学学生对移情性痴呆症护理的兴趣和热情的影响.
- 评估学生与痴呆和妄想有关的舒适度和知识的变化.
主要方法:
- 开发了一个痴呆症研讨会,并于2023年和2024年向第一和第二年级医学学生提供.
- 收集了学生的反和知识评估.
- 根据反,研讨会的内容被代地改进.
主要成果:
- 研讨会显著提高了医学学生对痴呆症护理主题的舒适度.
- 在研讨会结束后,学生们展示了对痴呆症和妄想症的增强知识.
- 积极的学生反表明,人们对移情性痴呆症护理的兴趣日益增长.
结论:
- 痴呆症研讨会是提高医学学生对痴呆症护理的准备能力的有效工具.
- 建议每年继续和完善研讨会.
- 这个倡议支持未来的医疗保健专业人员的发展,这些专业人员熟练在移情性痴呆症护理方面.
相关概念视频
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


